Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46620 | 17245221 | J Clin Gastroenterol | Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. | 2007 | Details |
| A46621 | 17244467 | Zhonghua Gan Zang Bing Za Zhi | [The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease]. | 2007 | Details |
| A46622 | 17244464 | Zhonghua Gan Zang Bing Za Zhi | [Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance]. | 2007 | Details |
| A46623 | 17219068 | Dig Dis Sci | The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. | 2007 | Details |
| A46624 | 17213068 | Evid Based Med | Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease. | 2006 | Details |
| A46625 | 17196150 | Zhonghua Gan Zang Bing Za Zhi | [Effect of adiponectin on nonalcoholic fatty liver disease]. | 2006 | Details |
| A46626 | 17164118 | Clin Liver Dis | Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection. | 2006 | Details |
| A46627 | 17160239 | Arq Gastroenterol | Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis. | 2007 | Details |
| A46628 | 17145635 | Am J Clin Pathol | Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease. | 2007 | Details |
| A46629 | 17136797 | Mayo Clin Health Lett | Nonalcoholic fatty liver disease. A growing problem. | 2006 | Details |
| A46630 | 17114290 | Proc Natl Acad Sci U S A | Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. | 2006 | Details |
| A46631 | 17099371 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. | 2006 | Details |
| A46632 | 17099068 | FASEB J | Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. | 2006 | Details |
| A46633 | 28381952 | Gastroenterol Hepatol (N Y) | The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process. | 2006 | Details |
| A46634 | 17064473 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between serum adiponectin level and non-alcoholic fatty liver disease in obese children]. | 2006 | Details |
| A46635 | 17058226 | Hepatology | Diabetic hepatosclerosis: a novel entity or a rare form of nonalcoholic fatty liver disease? | 2006 | Details |
| A46636 | 17049665 | J Hepatol | Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. | 2006 | Details |
| A46637 | 17036578 | Mayo Clin Proc | Long-term outcome of bariatric surgery: an interim analysis. | 2006 | Details |
| A46638 | 16996806 | Clin Gastroenterol Hepatol | Influence of high body mass index on outcome in acute liver failure. | 2006 | Details |
| A46639 | 16970019 | Am Fam Physician | Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. | 2006 | Details |
| A46640 | 16968796 | J Clin Endocrinol Metab | Serum resistin and hepatic fat content in nondiabetic individuals. | 2006 | Details |
| A46641 | 16952562 | Gastroenterology | Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. | 2006 | Details |
| A46642 | 16952281 | Am J Gastroenterol | The evolving role of leptin and adiponectin in chronic liver diseases. | 2006 | Details |
| A46643 | 16941682 | Hepatology | Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. | 2006 | Details |
| A46644 | 16938178 | Zhonghua Gan Zang Bing Za Zhi | [Association between tumor necrosis factor-alpha gene polymorphism and insulin resistance in nonalcoholic fatty liver disease]. | 2006 | Details |
| A46645 | 16932311 | Nat Clin Pract Endocrinol Metab | Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. | 2006 | Details |
| A46646 | 16925347 | Surg Obes Relat Dis | Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and bariatric surgery: a review. | 2006 | Details |
| A46647 | 16912555 | Curr Opin Clin Nutr Metab Care | Assessment of metabolic profile in a clinical setting. | 2006 | Details |
| A46648 | 16912127 | J Clin Endocrinol Metab | Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. | 2006 | Details |
| A46649 | 16907904 | Aliment Pharmacol Ther | Statins for non-alcoholic fatty liver disease: a new indication? | 2006 | Details |
| A46650 | 16901765 | Clin Gastroenterol Hepatol | A lean man with nonalcoholic fatty liver disease. | 2006 | Details |
| A46651 | 16847302 | Ann Intern Med | A rare cause of nonalcoholic fatty liver disease. | 2006 | Details |
| A46652 | 16846659 | J Hepatol | Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalities. | 2006 | Details |
| A46653 | 16844679 | Am J Physiol Gastrointest Liver Physiol | Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. | 2006 | Details |
| A46654 | 16831521 | Med Hypotheses | Unexpected beneficial effect in the use of ezetimibe in non-alcoholic fatty liver disease. | 2006 | Details |
| A46655 | 16828776 | Atherosclerosis | Non-alcoholic fatty liver disease as a determinant of cardiovascular disease. | 2006 | Details |
| A46656 | 16825939 | J Clin Gastroenterol | Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia. | 2006 | Details |
| A46657 | 16825675 | Am J Clin Nutr | Nonalcoholic fatty liver, nonalcoholic steatohepatitis, ectopic fat, and the glycemic index. | 2006 | Details |
| A46658 | 16799888 | J Gastroenterol | Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. | 2006 | Details |
| A46659 | 16780999 | J Hepatol | Bromocriptine reduces steatosis in obese rodent models. | 2006 | Details |
| A46660 | 16774486 | Expert Opin Drug Saf | Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139. | 2006 | Details |
| A46661 | 16771968 | Am J Gastroenterol | Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A46662 | 16770928 | Am Fam Physician | Information from your family doctor. Nonalcoholic fatty liver disease: what you should know. | 2006 | Details |
| A46663 | 16770927 | Am Fam Physician | Nonalcoholic fatty liver disease. | 2006 | Details |
| A46664 | 16767302 | Arq Bras Endocrinol Metabol | [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome]. | 2006 | Details |
| A46665 | 16762001 | Liver Int | Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. | 2006 | Details |
| A46666 | 16762000 | Liver Int | Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. | 2006 | Details |
| A46667 | 16753757 | Pathology | Invasive and non-invasive investigations for tamoxifen-induced non-alcoholic steatohepatitis (NASH): the benefit of computed tomography scan guided liver biopsy. | 2006 | Details |
| A46668 | 16729640 | Br J Hosp Med (Lond) | Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic. | 2006 | Details |
| A46669 | 16729327 | Hepatology | Impact of obesity on treatment of chronic hepatitis C. | 2006 | Details |
| A46670 | 16721237 | J Clin Gastroenterol | Invasive and noninvasive investigations for pediatric nonalcoholic liver fatty disease: time to move beyond liver biopsy. | 2006 | Details |
| A46671 | 16708768 | Altern Ther Health Med | The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease. | 2006 | Details |
| A46672 | 16706801 | J Gastroenterol Hepatol | Hepatocellular carcinoma and non-alcoholic fatty liver disease: Major liver diseases emerging from the Asia-Pacific Region. | 2006 | Details |
| A46673 | 16700132 | Zhonghua Gan Zang Bing Za Zhi | [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases]. | 2006 | Details |
| A46674 | 16698763 | Gut | A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations. | 2006 | Details |
| A46675 | 16679290 | Cell Metab | The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. | 2006 | Details |
| A46676 | 16678073 | Clin Gastroenterol Hepatol | Genetics of hepatobiliary diseases. | 2006 | Details |
| A46677 | 16618516 | J Hepatol | 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. | 2006 | Details |
| A46678 | 16618425 | Gastroenterology | Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. | 2006 | Details |
| A46679 | 16599851 | Clin Chem Lab Med | The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker? | 2006 | Details |
| A46680 | 16584696 | Gastroenterol Hepatol | [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. | 2006 | Details |
| A46681 | 16581333 | Am J Cardiol | An assessment of statin safety by hepatologists. | 2006 | Details |
| A46682 | 16557554 | Hepatology | COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. | 2006 | Details |
| A46683 | 16555318 | Liver Transpl | Nonalcoholic fatty liver disease and liver transplantation. | 2006 | Details |
| A46684 | 16550033 | Curr Opin Gastroenterol | Hepatobiliary pathology. | 2006 | Details |
| A46685 | 16540763 | J Clin Gastroenterol | Nonalcoholic steatohepatitis: a twenty-first century epidemic? | 2006 | Details |
| A46686 | 16540760 | J Clin Gastroenterol | Proceedings of a symposium on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. 2004. New York, New York, USA. | 2006 | Details |
| A46687 | 16532658 | Future Child | The consequences of childhood overweight and obesity. | 2006 | Details |
| A46688 | 16520485 | Ann Intern Med | The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. | 2006 | Details |
| A46689 | 16520484 | Ann Intern Med | The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. | 2006 | Details |
| A46690 | 16510031 | Curr Gastroenterol Rep | New treatments for nonalcoholic fatty liver disease. | 2006 | Details |
| A46691 | 16493965 | Rev Med Suisse | [Hepatology]. | 2006 | Details |
| A46692 | 16489319 | Panminerva Med | Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. | 2005 | Details |
| A46693 | 16478772 | Am J Physiol Endocrinol Metab | Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. | 2006 | Details |
| A46694 | 16471264 | J Soc Biol | [Experimental modulation of apoptosis: physiopathological and therapeutic targets]. | 2005 | Details |
| A46695 | 16470305 | Braz J Med Biol Res | Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. | 2006 | Details |
| A46696 | 16460473 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: the unfolding monster? | 2006 | Details |
| A46697 | 16456401 | J Pediatr Gastroenterol Nutr | Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children. | 2006 | Details |
| A46698 | 16444867 | Vasc Med | Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. | 2005 | Details |
| A46699 | 16435718 | Dtsch Med Wochenschr | [Nonalcoholic steatohepatitis]. | 2005 | Details |
| A46700 | 16423615 | J Pediatr | Direct diagnosis of Wilson disease by molecular genetics. | 2006 | Details |
| A46701 | 16405537 | Am J Gastroenterol | The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. | 2006 | Details |
| A46702 | 16392439 | Wien Med Wochenschr | Glycated hemoglobin and liver disease in diabetes mellitus. | 2005 | Details |
| A46703 | 16388571 | ACP J Club | Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease. | 2006 | Details |
| A46704 | 16369215 | Rev Gastroenterol Disord | Role of liver biopsy in the management of chronic liver disease: selective rather than routine. | 2005 | Details |
| A46705 | 16361039 | Clin Gastroenterol Hepatol | GIH clinical research update: 2004-2005. | 2005 | Details |
| A46706 | 16340637 | J Clin Gastroenterol | Liver disease in patients with diabetes mellitus. | 2006 | Details |
| A46707 | 16322887 | Breast Cancer Res Treat | Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist. | 2006 | Details |
| A46708 | 16311087 | Metabolism | Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations. | 2005 | Details |
| A46709 | 16306438 | Arterioscler Thromb Vasc Biol | Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A46710 | 16287799 | Ann Intern Med | Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. | 2005 | Details |
| A46711 | 16287793 | Ann Intern Med | The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. | 2005 | Details |
| A46712 | 16280437 | Am J Clin Nutr | Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. | 2005 | Details |
| A46713 | 16274837 | J Hepatol | Non-alcoholic steatohepatitis: from cell biology to clinical practice. | 2005 | Details |
| A46714 | 16269465 | Endocrinology | Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. | 2005 | Details |
| A46715 | 16265231 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease. | 2005 | Details |
| A46716 | 16265200 | Nat Clin Pract Gastroenterol Hepatol | Should nonalcoholic fatty liver disease be treated differently in elderly patients? | 2005 | Details |
| A46717 | 16259894 | Obes Surg | Non-alcoholic fatty liver disease: scoring systems need standardization, but are we ready? | 2005 | Details |
| A46718 | 16245220 | Turk J Gastroenterol | Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. | 2005 | Details |
| A46719 | 16237138 | Radiology | Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. | 2005 | Details |